Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non–Small Cell Lung Cancer
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.14046
Abstract: This cohort study compares the overall survival between patients who currently or formerly smoked with patients who never smoked and initiated pembrolizumab monotherapy as first-line treatment for advanced non–small lung cancer. read more here.
Keywords: first line; treatment advanced; overall survival; line treatment ... See more keywords
Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and sequential ablation in the treatment of advanced hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5366
Abstract: Evaluate the efficacy and safety of triple therapeutic method (Hepatic Aarterial Infusion Chemotherapy—HAIC, lenvatinib and sequential ablation) in the treatment for Advanced Hepatocellular carcinoma (Ad‐HCC). read more here.
Keywords: sequential ablation; treatment advanced; infusion chemotherapy; lenvatinib sequential ... See more keywords
A population‐based study of factors associated with systemic treatment in advanced prostate cancer decedents
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5401
Abstract: Life‐prolonging therapies (LPTs) are rapidly evolving for the treatment of advanced prostate cancer, although factors associated with real‐world uptake are not well characterized. read more here.
Keywords: prostate cancer; factors associated; treatment advanced; advanced prostate ... See more keywords
Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer
Sign Up to like & getrecommendations! Published in 2019 at "Abdominal Radiology"
DOI: 10.1007/s00261-019-02175-0
Abstract: Purpose To provide an overview for radiologists of the systemic agents used in the treatment of advanced epithelial ovarian cancer (EOC) and their associated toxicities. Results EOC is a common gynecological malignancy, with the majority… read more here.
Keywords: systemic therapies; epithelial ovarian; treatment advanced; advanced epithelial ... See more keywords
Surgical treatment of advanced penile cancer
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-017-2435-1
Abstract: PurposeTo evaluate the therapeutic effect of surgery in patients with advanced penile cancer, who have a dismal prognosis.Patients and methodsBetween September 2007 and July 2015, we treated 12 patients with surgical therapy.ResultsThe median follow-up period… read more here.
Keywords: surgical treatment; treatment advanced; advanced penile; cancer ... See more keywords
Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis
Sign Up to like & getrecommendations! Published in 2018 at "Targeted Oncology"
DOI: 10.1007/s11523-018-0559-0
Abstract: BackgroundCabozantinib has recently been evaluated as a first-line treatment in advanced renal cell carcinoma (aRCC).ObjectiveTo indirectly assess efficacy of cabozantinib versus standard-of-care (SoC) comparators in the first-line treatment of aRCC.MethodsWe conducted a systematic literature review… read more here.
Keywords: risk; cabozantinib; treatment advanced; treatment ... See more keywords
Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches
Sign Up to like & getrecommendations! Published in 2018 at "Targeted Oncology"
DOI: 10.1007/s11523-018-0585-y
Abstract: Advanced Merkel cell carcinoma (MCC) is a very aggressive, rare neuroendocrine tumor of the skin with a high frequency of locoregional recurrence and metastasis, and a high mortality rate. Surgical resection, sentinel lymph node biopsy,… read more here.
Keywords: cell carcinoma; treatment; treatment advanced; merkel cell ... See more keywords
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
Sign Up to like & getrecommendations! Published in 2022 at "Cancer cell"
DOI: 10.1016/j.ccell.2022.02.007
Abstract: Platinum-based chemotherapy is the standard first-line treatment for advanced esophageal squamous cell carcinoma (ESCC). In this phase 3 study (ClinicalTrial.gov: NCT03829969), 514 patients with treatment-naïve advanced ESCC were randomized (1:1) to receive toripalimab or placebo… read more here.
Keywords: advanced esophageal; treatment advanced; treatment; esophageal squamous ... See more keywords
Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
Sign Up to like & getrecommendations! Published in 2018 at "Current problems in cancer"
DOI: 10.1016/j.currproblcancer.2018.01.011
Abstract: Leiomyosarcomas (LMS) are rare tumors with poor prognosis owing to the high rate of recurrent and metastatic disease. The combination of doxorubicin (Adriamycin) plus ifosfamide and mesna (AIM) results in moderate response rates of 10%-30%.… read more here.
Keywords: doxorubicin treatment; treatment; treatment advanced; aim regimen ... See more keywords
Treatment of Advanced Heart Failure-Focus on Transplantation and Durable Mechanical Circulatory Support: What Does the Future Hold?
Sign Up to like & getrecommendations! Published in 2021 at "Heart failure clinics"
DOI: 10.1016/j.hfc.2021.05.013
Abstract: Heart transplantation (HTx) is the treatment of choice in patients with late-stage advanced heart failure (Advanced HF). Survival rates 1, 5, and 10 years after transplantation are 87%, 77%, and 57%, respectively, and the average life… read more here.
Keywords: treatment advanced; advanced heart; heart; heart failure ... See more keywords
Review of Talimogene Laherparepvec (T-VEC): A First in Class Oncolytic Viral Treatment of Advanced Melanoma.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2020.01.039
Abstract: Talimogene laherparepvec (T-VEC) is an oncolytic virus based on herpes simplex virus type-1 approved for intralesional treatment of advanced melanoma. In this article, we review the clinical literature on T-VEC for advanced melanoma and provide… read more here.
Keywords: advanced melanoma; talimogene laherparepvec; treatment advanced; laherparepvec vec ... See more keywords